Skip to content
Reference draft · Awaiting editorial review
inside your peptides.
Search

Archive article · Revised draft

GLP-1 studies: what lean-mass loss means

DXA substudies report changes in lean mass, not a direct measure of muscle loss. Different trial populations and methods limit comparisons, and individual nutrition or treatment decisions require qualified clinical guidance.

By Inside Your Peptides · Originally published · Language revised 2026-09-17

DXA substudies report changes in lean mass, not a direct measure of muscle loss. Different trial populations and methods limit comparisons, and individual nutrition or treatment decisions require qualified clinical guidance.

What the substudy actually measured

The SURMOUNT-1 body-composition publication used DXA scans in a subset of the main trial. It reported changes in fat mass and lean mass. Those measurements should not be relabeled as a direct measurement of skeletal-muscle loss or a prediction for an individual.

What comparisons leave out

Substudy selection, population, follow-up and measurement methods affect the result. Cross-trial percentages are not a head-to-head comparison. Weight-regain findings alone do not establish the composition of regained tissue. PubMed also lists a correction to the substudy, which should be read before reusing detailed numbers.

Keep decisions individualized

This page does not set protein targets, exercise prescriptions or medication plans. Symptoms, functional concerns and nutrition decisions should be discussed with the relevant qualified clinician. Trial results do not establish the quality or suitability of unrelated research products.

Sources used in this revision

Educational reading only. This page does not provide medical, dosing or personal-use guidance.

Back to the article archive